Full-Time
Biotechnology firm specializing in genetic testing
$77.2k - $96.4k/yr
Mid, Senior
Company Historically Provides H1B Sponsorship
San Carlos, CA, USA
Remote work is available for candidates based in the USA.
Upload your resume to see how it matches 9 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Natera specializes in genetic testing and diagnostics within the healthcare sector, offering advanced testing solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. The company utilizes cell-free DNA (cfDNA) testing to analyze DNA fragments in the blood, which helps detect minimal traces of cancer after treatment, guiding treatment decisions. One of their key products is the Signatera test, a custom ctDNA test for cancer patients, available through a remote access program. Natera also provides testing for organ health in transplant patients and offers a variety of tests for women's health, including the Panorama NIPT for prenatal screening. Their business model focuses on selling testing kits and services to healthcare providers and patients, often with insurance reimbursement. Natera distinguishes itself by combining specialized testing with genetic counseling services, allowing patients to receive personalized guidance remotely.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Austin, Texas
Founded
2004
Help us improve and share your feedback! Did you find this helpful?
Flexible medical plans
Investment options
Time off
Workplace perks
DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).
AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.
Last week, Natera (NasdaqGS:NTRA) announced a strategic expansion of its Board of Directors with the appointment of Monica Bertagnolli.
Natera launches HEROES trial for breast cancer treatment.
Lantheus competes with other companies in the medical and pharmaceutical industries, such as ShockWave Medical, Medpace Holdings, LivaNova, Apellis Pharmaceuticals, and Natera.